Ghent University Academic Bibliography

Show Sort by

Your filters: cql: parent exact "HEPATOLOGY"

Add to list
- Journal Article
- A1
Vasomodulators and liver transplantation for portopulmonary hypertension : evidence from a systematic review and meta‐analysis

Rebecca Deroo, Eric Trépo, Tom Holvoet (UGent) , Michel De Pauw (UGent) , Anja Geerts (UGent) , Xavier Verhelst (UGent) , Isabelle Colle (UGent) , Hans Van Vlierberghe (UGent) , Michael B Fallon and Sarah Raevens (UGent)

(2020) HEPATOLOGY.
Add to list
- Conference Paper
- C3
Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response

Rozanne de Veer, Maren H Harms, Christophe Corpechot, Willem J Lammers, Douglas Thorburn, Pietro Invernizzi, Harry LA Janssen, Pier Maria Battezzati, Frederik Nevens, Keith D Lindor, et al.

(2019) HEPATOLOGY. 70(suppl. 1). p.783A-785A
Add to list
- Conference Paper
- C3
Optimising trial design in late-stage primary biliary cholangitis : evaluating options for composite clinical endpoint studies

Carla Fiorella Murillo Perez, Willem J Lammers, Annarosa Floreani, Christophe Corpechot, Adriaan Van der Meer, Aliya Gulamhusein, Cyriel Ponsioen, Marco Carbone, Marlyn J Mayo, Pietro Invernizzi, et al.

(2019) HEPATOLOGY. 70(suppl. 1). p.793A-794A
Add to list
- Conference Paper
- C3
Oral vasodilator treatment and liver transplantation for portopulmonary hypertension : systematic review and meta-analysis of hemodynamic response and prognosis

Rebecca Deroo, Michel De Pauw (UGent) , Eric Trepo, Tom Holvoet (UGent) , Anja Geerts (UGent) , Xavier Verhelst (UGent) , Isabelle Colle (UGent) , Hans Van Vlierberghe (UGent) and Sarah Raevens (UGent)

(2019) HEPATOLOGY. 70(suppl. 1). p.272A-272A
Add to list
- Conference Paper
- C3
Derivation of a machine learning model to predict clinical outcome in patients with primary biliary cholangitis

Jorn Goet, Surain Roberts, Gideon Hirschfield, Pietro Invernizzi, Marco Carbone, Palak Trivedi, Christophe Corpechot, Harry LA Janssen, Rozanne de Veer, Willem J Lammers, et al.

(2019) HEPATOLOGY. 70(suppl. 1). p.760A-761A
Add to list
- Conference Paper
- C3
Ursodeoxycholic acid treatment-induced globe score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis

Rozanne de Veer, Maren H Harms, Jorn Goet, Christophe Corpechot, Douglas Thorburn, Pietro Invernizzi, Willem J Lammers, Harry LA Janssen, Pier Maria Battezzati, Frederik Nevens, et al.

(2019) HEPATOLOGY. 70(suppl. 1). p.776A-777A
Add to list
Angiopoietin-2 promotes pathological angiogenesis and is a therapeutic target in murine nonalcoholic fatty liver disease

Sander Lefere (UGent) , Frederique Van de Velde (UGent) , Anne Hoorens (UGent) , Sarah Raevens (UGent) , Sanne Van Campenhout (UGent) , Astrid Vandierendonck (UGent) , Sara Neyt (UGent) , Bert Vandeghinste (UGent) , Christian Vanhove (UGent) , Charlotte Debbaut (UGent) , et al.

(2019) HEPATOLOGY. 69(3). p.1087-1104
Add to list
- Journal Article
- A1
Connexin and pannexin (hemi)channels : emerging targets in the treatment of liver disease

Axelle Cooreman, Raf van Campenhout, Steven Ballet, Pieter Annaert, Bert Van Den Bossche, Isabelle Colle (UGent) , Bruno Cogliati and Mathieu Vinken

(2019) HEPATOLOGY. 69(3). p.1317-1323
Add to list
Why pulse oximetry is inaccurate in liver cirrhosis : ancient knowledge

Sarah Raevens (UGent) , Isabelle Colle (UGent) , Anja Geerts (UGent) and Hans Van Vlierberghe (UGent)

(2019) HEPATOLOGY. 69(1). p.462-463
Add to list
Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice

Sarah Raevens (UGent) , Anja Geerts (UGent) , Annelies Paridaens (UGent) , Sander Lefere (UGent) , Xavier Verhelst (UGent) , Anne Hoorens (UGent) , Jo Van Dorpe (UGent) , Tania Maes (UGent) , Ken Bracke (UGent) , Christophe Casteleyn (UGent) , et al.

(2018) HEPATOLOGY. 68(2). p.634-651

Academic Bibliography

Vasomodulators and liver transplantation for portopulmonary hypertension : evidence from a systematic review and meta‐analysis

Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response

Optimising trial design in late-stage primary biliary cholangitis : evaluating options for composite clinical endpoint studies

Oral vasodilator treatment and liver transplantation for portopulmonary hypertension : systematic review and meta-analysis of hemodynamic response and prognosis

Derivation of a machine learning model to predict clinical outcome in patients with primary biliary cholangitis

Ursodeoxycholic acid treatment-induced globe score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis

Angiopoietin-2 promotes pathological angiogenesis and is a therapeutic target in murine nonalcoholic fatty liver disease

Connexin and pannexin (hemi)channels : emerging targets in the treatment of liver disease

Why pulse oximetry is inaccurate in liver cirrhosis : ancient knowledge

Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice

Contents

Support

Contact